The dilated cardiomyopathy G159D mutation in cardiac troponin C weakens the anchoring interaction with troponin I

Biochemistry

Volumn 47, Issue 41, 2008, Pages 10950-10960

  Baryshnikova, Olga K ^a   Robertson, Ian M ^a   Mercier, Pascal ^a   Sykes, Brian D ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

FLOW INTERACTIONS; NUCLEAR MAGNETIC RESONANCE; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY;

C-DOMAIN; CARDIAC TROPONIN C; DILATED CARDIOMYOPATHY; MOLECULAR EFFECTS; MUTANT PROTEINS; NMR SPECTROS COPY; STRUCTURE AND DYNAMICS; TROPONIN C; TROPONIN I; WILD-TYPE;

ANIMAL CELL CULTURE;

MUTANT PROTEIN; TROPONIN C; TROPONIN I;

ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; CONGESTIVE CARDIOMYOPATHY; NITROGEN NUCLEAR MAGNETIC RESONANCE; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; NUCLEAR OVERHAUSER EFFECT; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; PROTON NUCLEAR MAGNETIC RESONANCE; X RAY ANALYSIS;

AMINO ACID SEQUENCE; CARDIOMYOPATHY, DILATED; HUMANS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; MUTATION; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; PROTEIN BINDING; TROPONIN C; TROPONIN I;

EID: 53749092307     PISSN: 00062960     EISSN: None     Source Type: Journal    
DOI: 10.1021/bi801165c     Document Type: Article

References (65)

1. Redwood, C. S., Moolman-Smook, J. C., and Watkins, H. (1999) Properties of mutant contractile proteins that cause hypertrophic cardiomyopathy. Cardiovasc. Res. 44, 20-36.
2. Seidman, J. G., and Seidman, C. (2001) The genetic basis for cardiomyopathy: From mutation identification to mechanistic paradigms. Cell 104, 557-567.
3. Hoffmann, B., Schmidt-Traub, H., Penot, A., Osterziel, K. J., and Gessner, R. (2001) First mutation in cardiac troponin C, L29Q, in a patient with hypertrophic cardiomyopathy. Hum. Mutat. 17, 524.
4. Mogensen, J., Murphy, R. T., Shaw, T., Bahl, A., Redwood, C., Watkins, H., Burke, M., Elliott, P. M., and McKenna, W. J. (2004) Severe disease expression of cardiac troponin C and T mutations in patients with idiopathic dilated cardiomyopathy. J. Am. Coll. Cardiol. 44, 2033-2040.
5. Lim, C. C., Yang, H., Yang, M., Wang, C. K., Shi, J., Berg, E. A., Pimentel, D. R., Gwathmey, J. K., Hajjar, R. J., Helmes, M., Costello, C. E., Huo, S., and Liao, R. (2008) A novel mutant cardiac troponin C disrupts molecular motions critical for calcium binding affinity and cardiomyocyte contractility. Biophys. J. 94, 3577-3589.
6. Li, M. X., Wang, X., and Sykes, B. D. (2004) Structural based insights into the role of troponin in cardiac muscle pathophysiology. J. Muscle Res. Cell Motil. 25, 559-579.
7. Sykes, B. D. (2003) Pulling the calcium trigger. Nat. Struct. Biol. 10, 588-589.
8. Lim, C. C., Yang, H., Yang, M., Wang, C. K., Shi, J., Berg, E. A., Pimentel, D. R., Gwathmey, J. K., Hajjar, R. J., Helmes, M., Costello, C. E., Huo, S., and Liao, R. (2008) A Novel Mutant Cardiac Troponin C Disrupts Molecular Motions Critical For Calcium Binding Affinity And Cardiomyocyte Contractility. Biophys. J. (in press).
9. Muir, L. A., Tschirgi, M. L., Rajapakse, I., and Chandra, M. (2006) Rat Cardiac Troponin C Mutations L29Q and G159D Decrease Myofilament Calcium Sensitivity Without Affecting Cooperativity. Biophysical Society Annual Meeting, pp 529, Salt Lake City, UT.
10. Schmidtmann, A., Lindow, C., Villard, S., Heuser, A., Mugge, A., Gessner, R., Granier, C., and Jaquet, K. (2005) Cardiac troponin C-L29Q, related to hypertrophic cardiomyopathy, hinders the transduction of the protein kinase A dependent phosphorylation signal from cardiac troponin I to C. FEBS J. 272, 6087-6097.
11. Dong, W. J., Xing, J., Ouyang, Y., An, J., and Cheung, H. C. (2008) Structural kinetics of cardiac troponin C mutants linked to familial hypertrophic and dilated cardiomyopathy in troponin complexes. J. Biol. Chem. 283, 3424-3432.
12. Dweck, D., Gomes, A. V., and Potter, J. D. (2005) Functional effects of human cardiac troponin C mutations linked to familial and dilated cardiomyopathis. Biophysical Society Annual Meeting, p 317a, Long Beach, CA.
13. Baryshnikova, O. K., Li, M. X., and Sykes, B. D. (2008) Modulation of cardiac troponin C function by the cardiac-specific N-terminus of troponin I: Influence of PKA phosphorylation and involvement in cardiomyopathies. J. Mol. Biol. 375, 735-751.
14. Biesiadecki, B. J., Kobayashi, T., Walker, J. S., John Solaro, R., and de Tombe, P. P. (2007) The Troponin C G159D Mutation Blunts Myofilament Desensitization Induced by Troponin I Ser23/24 Phosphorylation. Circ. Res. 100, 1486-1493.
15. Preston, L. C., Ashley, C. C., and Redwood, C. S. L. (2007) DCM troponin C mutant Gly159Asp blunts the response to troponin phosphorylation. Biochem. Biophys. Res. Commun. 360, 27-32.
16. Mirza, M., Marston, S., Willott, R., Ashley, C., Mogensen, J., McKenna, W., Robinson, P., Redwood, C., and Watkins, H. (2005) Dilated cardiomyopathy mutations in three thin filament regulatory proteins result in a common functional phenotype. J. Biol. Chem. 280, 28498-28506.
17. 2+-saturated form. Nature 424, 35-41.
18. Lindhout, D. A., Boyko, R. F., Corson, D. C., Li, M. X., and Sykes, B. D. (2005) The role of electrostatics in the interaction of the inhibitory region of troponin I with troponin C. Biochemistry 44, 14750-14759.
19. 2+- regulated structural changes in troponin. Proc. Natl. Acad. Sci. U.S.A. 102, 5038-5043.
20. Blumenschein, T. M., Tripet, B. P., Hodges, R. S., and Sykes, B. D. (2001) Mapping the interacting regions between troponins T and C. Binding of TnT and TnI peptides to TnC and NMR mapping of the TnT-binding site on TnC. J. Biol. Chem. 276, 36606-36612.
21. 2+-induced opening of the regulatory domain of skeletal troponin C are impaired by invariant site I or II Glu mutations. J. Biol. Chem. 275, 35106-35115.
22. Li, M. X., Corson, D. C., and Sykes, B. D. (2002) Structure determination by NMR. Isotope labeling. Methods Mol. Biol. 173, 255-265.
23. 2+-dependent regulation of muscle contraction. J. Mol. Biol. 271, 728-750.
24. Johnson, B. A., and Blevins, R. A. (1994) NMRView: A computer program for the visualization and analysis of NMR data. J. Biomol. NMR 4, 603-614.
25. 15N NMR relaxation data. J. Biomol. NMR 36, 215-224.
26. Lipari, G., and Szabo, A. (1982) Model-Free Approach to the Interpretation of Nuclear Magnetic-Resonance Relaxation in Macromolecules. 1. Theory and Range of Validity. J. Am. Chem. Soc. 104, 4546-4559.
27. Delaglio, F., Grzesiek, S., Vuister, G. W., Zhu, G., Pfeifer, J., and Bax, A. (1995) NMRPipe: A multidimensional spectral processing system based on UNIX pipes. J. Biomol. NMR 6, 277-293.
28. Slupsky, C. M., Boyko, R. F., Booth, V. K., and Sykes, B. D. (2003) Smartnotebook: A semi-automated approach to protein sequential NMR resonance assignments. J. Biomol. NMR 27, 313-321.
29. Guntert, P. (2004) Automated NMR strucutre calculation with CYANA. Methods Mol. Biol. 278, 353-378.
30. Jee, J., and Guntert, P. (2003) Influence of the completeness of chemical shift assignments on NMR structures obtained with automated NOE assignment. J. Struct. Funct. Genomics 4, 179-189.
31. Cornilescu, G., Delaglio, F., and Bax, A. (1999) Protein backbone angle restraints from searching a database for chemical shift and sequence homology. J. Biomol. NMR 13, 289-302.
32. Linge, J. P., Williams, M. A., Spronk, C. A., Bonvin, A. M., and Nilges, M. (2003) Refinement of protein structures in explicit solvent. Proteins 50, 496-506.
33. Schwieters, C. D., Kuszewski, J. J., Tjandra, N., and Clore, G. M. (2003) The Xplor-NIH NMR molecular structure determination package. J. Magn. Reson. 160, 65-73.
34. Laskowski, R. A., MacArthur, M. W., Moss, D. S., and Thornton, J. M. (1993) PROCHECK: A program to check the stereochemical quality of protein structures. J. Appl. Crystallogr. 26P, 283-291.
35. Hooft, R. W., Vriend, G., Sander, C., and Abola, E. E. (1996) Enors in protein structures. Nature 381, 272.
36. Li, M. X., Wang, X., Lindhout, D. A., Buscemi, N., Van Eyk, J. E., and Sykes, B. D. (2003) Phosphorylation and mutation of human cardiac troponin I deferentially destabilize the interaction of the functional regions of troponin I with troponin C. Biochemistry 42, 14460-14468.
37. Lindhout, D. A., and Sykes, B. D. (2003) Structure and dynamics of the C-domain of human cardiac troponin C in complex with the inhibitory region of human cardiac troponin I. J. Biol. Chem. 278, 27024-27034.
38. Gasmi-Seabrook, G. M., Howarth, J. W., Finley, N., Abusamhadneh, E., Gaponenko, V., Brito, R. M., Solaro, R. J., and Rosevear, P. R. (1999) Solution structures of the C-terminal domain of cardiac troponin C free and bound to the N-terminal domain of cardiac troponin I. Biochemistry 38, 8313-8322.
39. Bloembergen, N., Purcell, E. M., and Pound, R. V. (1948) Relaxation Effects in Nuclear Magnetic Resonance Absorption. Phys. Rev. 73, 679-712.
40. Baryshnikova, O. K., and Sykes, B. D. (2006) Backbone dynamics of SDF-1α determined by NMR: Interpretation in the presence of monomer-dimer equilibrium. Protein Sci. 15, 2568-2578.
41. Mercier, P., Spyracopoulos, L., and Sykes, B. D. (2001) Structure, dynamics, and thermodynamics of the structural domain of troponin C in complex with the regulatory peptide 1-40 of troponin I. Biochemistry 40, 10063-10077.
42. Cantor, C. R., and Schimmel, P. R. (1980) Biophysical Chemistry, Part II, Techniques for the study of biological structure and function, W. H. Freeman, New York.
43. Tanford, C. (1961) Physical chemistry of macromolecules, John Wiley & Sons, Inc., New York.
44. Wuthrich, K. (1986) NMR of Proteins and Nucleic Acids, John Wiley & Sons, Inc., New York.
45. 13C HMQC-NOESY experiment for extracting intermolecular NOE contacts in molecular complexes. FEBS Lett. 350, 87-90.
46. Robertson, I. M., Spyracopoulos, L., and Sykes, B. D. (2007) The evaluation of isotope editing and filtering for protein-ligand interaction elucidation by NMR, Proceedings for the International School of Biological Magnetic Resonanse, 8th Course on Biophysics and the Challenges of Emerging Threats (Puglisi, J. D., Ed.) NATO Science Series Life and Behavioural Sciences, IOS Press, Amsterdam.
47. Gemmecker, G., Olejniczak, E. T., and Fesik, S. W. (1992) An Improved Method for Selectively Observing Protons Attached to C-12 in the Presence of H-1-C-13 spin Pairs. J. Magn. Reson. 96, 199-204.
48. Ikura, M., and Bax, A. (1992) Isotope-Filtered 2d NMR of a Protein Peptide Complex: Study of a Skeletal-Muscle Myosin Light Chain Kinase Fragment Bound to Calmodulin. J. Am. Chem. Soc. 114, 2433-2440.
49. Ogura, K., Terasawa, H., and Inagaki, F. (1996) An improved double-tuned and isotope-filtered pulse scheme based on a pulsed field gradient and a wide-band inversion shaped pulse. J. Biomol. NMR 8, 492-498.
50. 2+-loaded structure. Biochemistry 43, 11371-11379.
51. Li, M. X., Saude, E. J., Wang, X., Pearlstone, J. R., Smillie, L. B., and Sykes, B. D. (2002) Kinetic studies of calcium and cardiac troponin I peptide binding to human cardiac troponin C using NMR spectroscopy. Eur. Biophys. J. 31, 245-256.
52. Tripet, B., De Crescenzo, G., Grofhe, S., O'Connor-McCourt, M., and Hodges, R. S. (2003) Kinetic analysis of the interactions between troponin C (TnC) and troponin I (TnI) binding peptides: Evidence for separate binding sites for the 'structural' N-terminus and the 'regulatory' C-terminus of TnI on TnC J. Mol. Recognit. 16, 37-53.
53. Sheng, Z., Pan, B. S., Miller, T. E., and Potter, J. D. (1992) Isolation, expression, and mutation of a rabbit skeletal muscle cDNA clone for troponin I. The role of the NH2 terminus of fast skeletal muscle troponin I in its biological activity. J. Biol. Chem. 267, 25407-25413.
54. 2+ regulation of muscle contraction. J. Biol. Chem. 270, 2557-2562.
55. De Nicola, G., Burkart, C., Qiu, F., Agianian, B., Labeit, S., Martin, S., Bullard, B., and Pastore, A. (2007) The structure of Lethocerus troponin C: Insights into the mechanism of stretch activation in muscles. Structure 15, 813-824.
56. Pan, B. S., and Johnson, R. G., Jr. (1996) Interaction of cardiotonic thiadiazinone derivatives with cardiac troponin C. J. Biol. Chem. 271, 817-823.
57. Kleerekoper, Q., and Putkey, J. A. (1999) Drug binding to cardiac troponin C. J. Biol. Chem. 274, 23932-23939.
58. 2+ sensitizer EMD 57033 and cardiac troponin I inhibitory peptide. Biochemistry 39, 8782-8790.
59. 2+ sensitizing drug EMD 57033. J. Biol. Chem. 276, 25456-25466.
60. i waves in cardiac myocytes. Am. J. Physiol. 270, C148-C159.
61. Takamatsu, T., and Wier, W. G. (1990) Calcium waves in mammalian heart: Quantification of origin, magnitude, waveform, and velocity. FASEB J. 4, 1519-1525.
62. Li, M. X., Spyracopoulos, L., and Sykes, B. D. (1999) Binding of cardiac troponin-I147-163 induces a structural opening in human cardiac troponin-C. Biochemistry 38, 8289-8298.
63. Finley, N., Abbott, M. B., Abusamhadneh, E., Gaponenko, V., Dong, W., Gasmi-Seabrook, G., Howarth, J. W., Ranee, M., Solaro, R. J., Cheung, H. C., and Rosevear, P. R. (1999) NMR analysis of cardiac troponin C-troponin I complexes: Effects of phosphorylation. FEBS Lett. 453, 107-112.
64. Gaponenko, V., Abusamhadneh, E., Abbott, M. B., Finley, N., Gasmi-Seabrook, G., Solaro, R. J., Ranee, M., and Rosevear, P. R. (1999) Effects of troponin I phosphorylation on conformational exchange in the regulatory domain of cardiac troponin C. J. Biol. Chem. 274, 16681-16684.
65. Keane, N. E., Quirk, P. G., Gao, Y., Patchell, V. B., Perry, S. V., and Levine, B. A. (1997) The ordered phosphorylation of cardiac troponin I by the cAMP-dependent protein kinase: Structural consequences and functional implications. Eur. J. Biochem. 248, 329-337.